Weak Oversight Of Chinese Pharmaceutical Companies Threatens Global Supply Chain
Financial Times: China drug scandals highlight risks to global supply chain
“Drug safety scandals in recent weeks have underlined the risks to international consumers posed by weak oversight in China, the world’s largest supplier of active pharmaceutical ingredients…” (Hancock/Xueqiao, 8/6).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.